PowerPanel – Quality vs. Productivity, the Sterile Processing Battle Royale

The panel discussion, sponsored by Censis Technologies, delves into the ongoing debate surrounding quality versus productivity within the sterile processing industry. The conversation is moderated by Hank Balch, Founder and President of Beyond Clean, and features experts from the field. The central issue revolves around differing perspectives and disagreements within the industry regarding the balance between these two critical aspects. Discrepancies arise due to various factors, including historical practices, evolving industry standards, and variations in institutional priorities. The challenge lies in finding the right equilibrium between the imperative to boost productivity with a limited workforce while preserving the high standards of quality within sterile processing. This multifaceted debate grapples with how best to measure and quantify these complex elements in the field.

Recent Episodes

In this impactful episode of the ConCensis podcast, host Yasmeen Hassan sits down with Robby Miller, Sterile Processing Manager at St. Joseph’s Hospital Medical Center, to explore how artificial intelligence is revolutionizing the field of sterile processing. With nearly 30 years of experience in healthcare, Miller shares his journey from EMT to SPD leader, offering…

In the last two decades, oncology has undergone a transformation with over 300 new cancer therapies approved by the FDA—many offering novel mechanisms of action. Despite these innovations, resistance to treatment remains a critical challenge, with cancer cells evolving or adapting to evade even the most advanced therapeutics. This issue is particularly pressing given that…

In an era where precision and predictability define the future of oncology, organoid technology is emerging as a transformative tool in drug discovery. These miniature, lab-grown 3D tissues mirror real human biology more closely than traditional 2D models or even animal systems, offering researchers the potential to predict patient-specific drug responses. As organoids become more…